Free Trial

Silverback Therapeutics (NASDAQ:SBTX) Shares Up 0.4% - Time to Buy?

Silverback Therapeutics logo with Medical background

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Silverback Therapeutics, Inc. (NASDAQ:SBTX - Get Free Report)'s share price shot up 0.4% on Monday . The stock traded as high as $14.91 and last traded at $14.53. 2,890,457 shares changed hands during mid-day trading, an increase of 755% from the average session volume of 337,931 shares. The stock had previously closed at $14.47.

Silverback Therapeutics Stock Up 0.4%

The company has a market cap of $523.92 million, a price-to-earnings ratio of -6.00 and a beta of 0.60. The company has a fifty day simple moving average of $16.83 and a two-hundred day simple moving average of $14.33.

Silverback Therapeutics Company Profile

(Get Free Report)

Silverback Therapeutics, Inc, a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Silverback Therapeutics Right Now?

Before you consider Silverback Therapeutics, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Silverback Therapeutics wasn't on the list.

While Silverback Therapeutics currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Follow the Money: 5 Stocks Institutions Are Buying NOW
Palantir’s Soaring Valuation—Justified or Overhyped?
3 Stocks With Explosive Upside

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines